US Payrolls Surpass Expectations in April But Underlying Red Flags Emerge Ryan Cohen Signals Intent to Acquire eBay Backed by GameStops Balance Sheet Strength AIResistant HALO Investing Theme Gains Traction with New ETF Launch Treasury Yield Surge Prompts Bond Investors to Seek Alternative FixedIncome Opportunities Intel Pushes PC Makers to Adopt 18A Chips as AI Demand Fuels Semiconductor Growth Bill Gates Discusses Meeting with Trump Elon Musks Dogecoin and Personal History in WSJ Interview Ahead of Memoir CTEV Q1 2026 Earnings Significant EPS Miss Amidst Operational Challenges NCR Atleos Corporation Q1 2026 Earnings EPS Falls Short of Estimates Stock Slides REAX Q1 2026 Earnings NarrowerThanExpected Loss Fails to Move Shares SNAP Q1 2026 Earnings EPS Slightly Exceeds Estimates Stock Edges Higher SFNC Q1 2026 Earnings Slight EPS Miss Amid Stable Operations KAPA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Clinical Pipeline Shoulder Innovations Inc SI Slips 33 as Stock Tests Key Support Zone IAF Sees Modest Decline as Fund Holds Above Key Support Avino Silver Gold Mines ASM Gains 74 Amid Silver Sector Strength BrightView Holdings BV Edges Higher Testing Key Resistance Zone Fortuna Mining Corp Surges 476 as Gold Miner Tests Resistance Zone Chicago Fed Releases Latest Labor Market Indicators Insights into US Employment Trends RILYZ Q1 2024 Earnings Negative EPS Reflects Challenging Quarter for BRC Group Holdings Macys M Surges Over 6 Key Levels to Watch After the Breakout Kevin Warsh Faces Internal Fed Divisions Over Interest Rate Policy Amid Inflation and Yield Surge WLKP Q1 2026 Earnings EPS Misses Estimates Amid Stable Distribution Units Edge Higher Stephen Miran Departs Federal Reserve Paving Way for Kevin Warshs Leadership OpenAI Reportedly Plans Confidential IPO Filing by May 22 Potential Valuation Up to 1 Trillion UK Governance Concerns Mount as MountbattenWindsor Papers Reveal Lapses in Trade Envoy Appointment Process Woodward WWD Q1 2026 Earnings Strong EPS Beat Bolstered by Operational Gains Yet Shares Edge Lower Adagene Q2 2025 Earnings Clinical Progress Overshadows EPS Miss Shares Jump